Found 19 matching trials
A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
PHASE1Phase Ib/II open label, multicenter study to evaluate the efficacy and safe...
Status
Active Not Recruiting
Location
Zhejiang Cancer Hospital
A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer
PHASE2This trial is a Phase II study. The purpose of this study is to evaluate th...
Status
Active Not Recruiting
Location
Hunan Cancer Hospital
A Study of Ivonescimab in First-Line ES-SCLC
PHASE2The goal of this clinical trial is to learn if different combinations of a ...
Location
Cancer Hospital Chinese Academy of Medical Sciences
A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia
PHASE1This is a open label, phase Ib/II study. All patients are diagnosed with AM...
Status
Active Not Recruiting
Location
The First Affiliated Hospital,Zhejiang University School of Medicine
Ligufalimab and Cadonilimab in Advanced Liver Cancers
PHASE2The goal of this clinical trial is to find out if the combination of Ligufa...
Location
University of Texas Southwestern Medical Center
A Trial of AK117 (Anti-CD47) in Patients With Myelodysplastic Syndrome
PHASE1This is a open label, phase I/II study. All patients are diagnosed with hig...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Soochow University
A Phase 1 Dose Escalation and Expansion Study of AK117
PHASE1This is a multicenter, open label, single arm, Phase 1,dose escalation and ...
Location
FuDan University Shanghai Cancer Center
Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
PHASE2This trial is a Phase II study. All patients are resectable Gastric or Gast...
Location
Tianjin Provincial Tumor Hospital
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104
PHASE1This was a first-in-human, Phase 1 study designed to evaluate the safety, t...
Location
Blacktown Hospital
A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma
PHASE1This is a phase I/II study. All subjects are patients diagnosed with relaps...
Location
Beijing Cancer Hospital